Embody review
Embody names its clinical network and dispensing partners. Its promotion and monthly Flat terms still describe different purchase decisions.
The verdict
The relevant distinction is between Embody Start and Embody Flat. Flat's unbundled terms list $199 for a month of semaglutide and $299 for tirzepatide. A lower homepage promotion does not establish which renewal agreement a patient receives.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 50
- From
- From $199/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Named
Embody connects patients with remote clinical care for compounded GLP-1 injections. The homepage presents semaglutide and tirzepatide. Although the terms also mention gum formulations, a legal price schedule alone is not evidence that an oral product can currently be ordered.
Who writes the prescription, and what do they see?
OpenLoop Health is identified in the footer as the clinical network. The preliminary assessment screens eligibility, while the prescribing decision comes from a clinician after checkout. Neither completing the form nor paying is proof that treatment will be prescribed.
The public pages identify the care network and four possible dispensing partners. They do not assign a named pharmacy to a particular visitor before intake. Ask who will supply the medication and how follow-up works; a published partner list establishes disclosure, not the quality of an individual encounter.
What happens when the dose goes up?
A program described as fixed monthly pricing is not a published dosing schedule. Confirm the prescribed concentration, supply and charge at a higher dose with the care team rather than assuming the advertised vial represents every treatment stage.
What the price includes
Under the Flat heading, the legal terms give semaglutide a monthly rate of $199 and add $100 for injectable tirzepatide. Longer commitments have their own discounts. The separate Start schedule changes after the introductory month. These are the published Flat monthly terms; the current promotion may have different conditions. A patient-specific checkout quote has not been verified.
What it claims, and what it cites
The website lists Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. Their appearance in the disclosure does not confirm which one will dispense a patient's medication. Compounded drugs are not FDA-approved, and results from trials of approved formulations do not validate a particular compounded preparation.
Where it holds up, and where it does not
- Strength: OpenLoop Health identified as the clinical network
- Strength: Four dispensing partners disclosed
- Strength: Separate subscription programs explained in legal terms
- Limitation: Promotional homepage and Flat terms quote different offers
- Limitation: The assigned pharmacy is not established before intake
- Limitation: Prepaid unused treatment is generally non-refundable
What the evidence says about this kind of treatment
The assessment above is about Embody. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader prepared to confirm the prescribing arrangements and the selected subscription agreement before enrolling.
- Wrong for
- A reader who needs prepaid treatment to remain refundable when circumstances change.
The evidence behind what Embody prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Embody compares
| Seller | Who it suits | Go |
|---|---|---|
 Lean Meds | Readers willing to clarify the prescription and renewal details | See Lean Meds → |
 Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
 Maximus | A reader weighing a compounded preparation against the manufacturer's own pen, with both priced on one seller's pages. | See Maximus → |
More GLP-1 telehealth sellers reviews: GobyMedsGoldspan HealthGood Girl RxGood Life MedsGoodRxGreen Cap Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is the promotional figure the monthly Flat rate?
- The published Flat schedule sets semaglutide at $199, with another $100 for tirzepatide. That is the terms-based rate used here. A separate homepage offer and the introductory Start program should not be treated as interchangeable.
- Does Embody identify its pharmacies?
- Yes. Its disclosures list four partners, alongside OpenLoop Health for clinical care. Confirm the pharmacy attached to your prescription because the list describes possible partners rather than your individual dispensing arrangement.
- What happens if I stop treatment early?
- Its policy generally does not refund the remainder of a bundle. Medical disqualification is the stated exception. Cancellation must reach the service at least 72 hours ahead of the next billing date; ask for confirmation that future renewal has stopped.
- Is Embody expensive compared with other GLP-1 telehealth sellers?
- Embody publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Embody above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.